Jump to content


Congrats to Margaret, Platinum Member with 1,000 posts and 10 Years of Forums Membership!


Clinical Risk Assessment Of Organ Manifestations In Systemic Sclerosis


  • Please log in to reply
No replies to this topic

#1 Guest_Sherrill_*

Guest_Sherrill_*
  • Guests

Posted 10 April 2007 - 08:13 PM

Clinical risk assessment of organ manifestations in systemic sclerosis - a report from the EULAR Scleroderma Trials And Research (EUSTAR) group data base. Diffuse cutaneous (dcSSc) and a limited cutaneous (lcSSc) subsets are associated with particular organ manifestations, but in this analysis the clinical distinction appeared superseded by an antibody based classification in predicting some scleroderma complications. PubMed. Ann rheumatologist Dis. 2007 Feb 1. (Also see: Types of Scleroderma and Antibodies)

This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information. http://www.sclero.org/news/a-to-z.html